ArticleOncogene2003

The proteasome inhibitor PS-341 overcomes TRAIL resistance in Bax and caspase 9-negative or Bcl-xL overexpressing cells.

Thomas R Johnson et al.PubMed ↗Publisher ↗

No numbers read from the abstract.